BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36348010)

  • 21. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.
    Chen F; Mo J; Zhang L
    Tumour Biol; 2016 Oct; 37(10):13403-13412. PubMed ID: 27460090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LINC00324 accelerates the proliferation and migration of osteosarcoma through regulating WDR66.
    Wu S; Gu Z; Wu Y; Wu W; Mao B; Zhao S
    J Cell Physiol; 2020 Jan; 235(1):339-348. PubMed ID: 31225659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CtBP1-HDAC1/2-IRF1 transcriptional complex represses the expression of the long noncoding RNA GAS5 in human osteosarcoma cells.
    Zhang X; Du K; Lou Z; Ding K; Zhang F; Zhu J; Chang Z
    Int J Biol Sci; 2019; 15(7):1460-1471. PubMed ID: 31337976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
    Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
    J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. lncRNA SNHG1 negatively regulates miRNA‑101‑3p to enhance the expression of ROCK1 and promote cell proliferation, migration and invasion in osteosarcoma.
    Deng R; Zhang J; Chen J
    Int J Mol Med; 2019 Mar; 43(3):1157-1166. PubMed ID: 30592267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The lncRNA BORG Drives Breast Cancer Metastasis and Disease Recurrence.
    Gooding AJ; Zhang B; Jahanbani FK; Gilmore HL; Chang JC; Valadkhan S; Schiemann WP
    Sci Rep; 2017 Oct; 7(1):12698. PubMed ID: 28983112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
    Yang C; Wu K; Wang S; Wei G
    J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA SNHG4 promotes tumour growth by sponging miR-224-3p and predicts poor survival and recurrence in human osteosarcoma.
    Xu R; Feng F; Yu X; Liu Z; Lao L
    Cell Prolif; 2018 Dec; 51(6):e12515. PubMed ID: 30152090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA GClnc1 promotes tumorigenesis in osteosarcoma by inhibiting p53 signaling.
    Sui Y; Han Y; Zhao X; Li D; Li G
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):36-42. PubMed ID: 30454890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. lncRNA C2dat1 Promotes Cell Proliferation, Migration, and Invasion by Targeting miR-34a-5p in Osteosarcoma Cells.
    Jia D; Niu Y; Li D; Liu Z
    Oncol Res; 2018 Jun; 26(5):753-764. PubMed ID: 28810936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma.
    Wang Y; Zeng X; Wang N; Zhao W; Zhang X; Teng S; Zhang Y; Lu Z
    Mol Cancer; 2018 May; 17(1):89. PubMed ID: 29753317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIF‑1α‑induced upregulation of lncRNA UCA1 promotes cell growth in osteosarcoma by inactivating the PTEN/AKT signaling pathway.
    Li T; Xiao Y; Huang T
    Oncol Rep; 2018 Mar; 39(3):1072-1080. PubMed ID: 29328452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1α in osteosarcoma.
    Tan H; Zhao L
    J Cell Biochem; 2019 Apr; 120(4):6502-6514. PubMed ID: 30485482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linc00460 promotes osteosarcoma progression via miR-1224-5p/FADS1 axis.
    Lian H; Xie P; Yin N; Zhang J; Zhang X; Li J; Zhang C
    Life Sci; 2019 Sep; 233():116757. PubMed ID: 31419446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The long noncoding RNA cancer susceptibility candidate 2 inhibits tumor progression in osteosarcoma.
    Lu L; Dai Z; Luo Q; Lv G
    Mol Med Rep; 2018 Jan; 17(1):1947-1953. PubMed ID: 29257211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.
    Wang Y; Zhao Z; Zhang S; Li Z; Li D; Yang S; Zhang H; Zeng X; Liu J
    J Cell Biochem; 2018 Nov; 119(10):8481-8489. PubMed ID: 29987852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223.
    Dai J; Xu L; Hu X; Han G; Jiang H; Sun H; Zhu G; Tang X
    Biomed Pharmacother; 2018 Oct; 106():1441-1447. PubMed ID: 30119217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of lncRNA H19 inhibits migration and invasion of human osteosarcoma through the NF-κB pathway.
    Zhao J; Ma ST
    Mol Med Rep; 2018 May; 17(5):7388-7394. PubMed ID: 29568924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA-p21 inhibited the proliferation of osteosarcoma cells via the miR-130b/PTEN/AKT signaling pathway.
    Han W; Liu J
    Biomed Pharmacother; 2018 Jan; 97():911-918. PubMed ID: 29136769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA LOC100129620 promotes osteosarcoma progression through regulating CDK6 expression, tumor angiogenesis, and macrophage polarization.
    Chen Y; Tang G; Qian H; Chen J; Cheng B; Zhou C; Shen Y
    Aging (Albany NY); 2021 May; 13(10):14258-14276. PubMed ID: 34015762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.